Compounded peptides just got their biggest win yet. On October 28, 2026, the U.S. Department of Health and Human Services announced that licensed compounding pharmacies across the country can now make and dispense six of the most talked-about peptides: BPC-157, TB-500, KPV, MOTS-c, Semax, and Epitalon.
For years, people chasing faster recovery, sharper focus, and healthier aging had two bad options: go without, or roll the dice on “research use only” vials from the internet. That era is ending. This move pulls peptides out of the gray market and puts them where they belong: in licensed U.S. pharmacies, prescribed by real doctors.
At BROND, we’ve been ready for this moment. All six compounded peptides are coming soon to our physician-guided platform.
HHS is using what’s called enforcement discretion: it will not take action against licensed compounding pharmacies that make these six peptides while the FDA finalizes a formal rule. That means patients get access now instead of waiting years for the standard rulemaking process to play out.
This didn’t come out of nowhere. An FDA advisory panel voted in July 2026 to recommend allowing compounding pharmacies to produce these peptides. HHS leadership has been clear about the goal: move Americans away from unregulated online products and toward safer, pharmacy-made compounds.
The policy also raises the bar on quality. Under the new framework, compounding pharmacies must:
Those guardrails are exactly what the gray market never offered. The peptides themselves are not yet FDA-approved drugs, and the FDA is still gathering data and public comment before a final ruling. But for the first time, Americans have a clear, legitimate path to compounded peptides through a doctor and a licensed pharmacy.
Each of these peptides has built a following for a reason. Here’s a quick look at what each one is and what the research is exploring. Much of the current evidence comes from early-stage and animal studies, which is why working with a licensed provider matters.
Until now, most peptides sold online came labeled “for research use only.” No prescription, no doctor, no pharmacy standards, and no way to know what was actually in the vial. HHS called it out directly: the goal of this policy is to steer people away from black-market peptides and toward safe, pharmacy-made compounds.
That’s the standard BROND was built on. When you get compounded peptides through a licensed provider, you get:
Peptides aren’t for everyone, and they aren’t a shortcut. But for people who take their health seriously, this is the safest, most legitimate access to compounded peptides Americans have ever had.
BROND’s compounded peptide lineup is coming soon. We’re building it the right way: every order reviewed by a U.S.-licensed physician, filled by licensed U.S. pharmacies, and held to the new HHS sourcing, identity, and purity standards. Join the BROND newsletter to be first in line when BPC-157, TB-500, KPV, MOTS-c, Semax, and Epitalon go live.
In the meantime, you don’t have to sit on the sidelines. These BROND treatments, available now, support many of the same goals:
Start with what’s available today, and your provider can help you add peptides to your plan as soon as they launch.
BROND helps men and women who never settle stay in the fight. We offer science-backed treatments for energy, longevity, recovery, weight loss, hair, and sexual health, all 100% online. Every prescription is reviewed and written by a board-certified, U.S.-licensed physician, and every order ships free and discreetly to your door in 2 to 5 days. We’re HIPAA compliant, LegitScript certified, and 100% American made.
America’s Health, Reclaimed. Built on Faith, Family, Freedom, and Fortitude.
This content is for informational purposes only and is not a substitute for professional medical advice. Compounded peptides are not FDA-approved drugs. Prescription products require an online consultation with a licensed provider, who will determine if treatment is appropriate. Individual results may vary.
